(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 24.17% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 40.95%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.76%.
Uniqure Nv's revenue in 2023 is $106,483,000.On average, 8 Wall Street analysts forecast QURE's revenue for 2023 to be $7,972,082,020, with the lowest QURE revenue forecast at $751,719,760, and the highest QURE revenue forecast at $12,976,562,357. On average, 5 Wall Street analysts forecast QURE's revenue for 2024 to be $8,408,549,305, with the lowest QURE revenue forecast at $1,487,465,475, and the highest QURE revenue forecast at $21,738,795,810.
In 2025, QURE is forecast to generate $9,775,880,566 in revenue, with the lowest revenue forecast at $2,386,710,238 and the highest revenue forecast at $22,622,066,528.